Lovisa returns to pre-COVID levels on European acquisition
Por um escritor misterioso
Descrição
On the back of a European acquisition, Jewellery retailer Lovisa (ASX: LOV) has seen its shares bounce back to levels not seen since the COVID-19 pandemic slamm
Dysregulation of the Kynurenine Pathway, Cytokine Expression
The gut virome: A new microbiome component in health and disease
Evaluation of Intestinal Fibrosis with 68Ga-FAPI PET/MR
AMT - Relations - Development and characterization of the Portable
JCM, Free Full-Text
Part 8: Adult Advanced Cardiovascular Life Support
Hygiene, Free Full-Text
Cerebral hypoperfusion in post-COVID-19 cognitively impaired
Central nervous system biomarkers GFAp and NfL associate with post
Mapping the nucleolar proteome reveals a spatiotemporal
Remote photobiomodulation targeted at the abdomen or legs provides
N-CSR
Themes that matter to Australian Value investors
ACP - Relations - Explaining apparent particle shrinkage related
de
por adulto (o preço varia de acordo com o tamanho do grupo)